InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by jérémy pessiot, Deputy CEO. Director active across 1 companies, notably AFYREN. Aggregated, 7 disclosures have been published. Total volume traded: €118k. The latest transaction was filed on 15 December 2025 (Acquisition). Regulator: AMF. All data is free.
Declarations7 total
€100,659188,500 shares@ €0.5340.18% mcap85.4% of flow
ActionEuronext Growth Paris
2025DD1086452·
Ideal exit: 11 Sept 2026 (T+270)
€2,0201,098 shares@ €1.840.0036% mcap1.7% of flow
ActionEuronext Growth Paris
2024DD950358·
Ideal exit: 8 Nov 2024 (T+270)
€3,098750 shares@ €4.130.0055% mcap2.6% of flow
ActionEuronext Growth Paris
2023DD894770·
Ideal exit: 8 Jan 2024 (T+270)
€9,7982,000 shares@ €4.8990.017% mcap8.3% of flow
ActionEuronext Growth Paris
2023DD891098·
Ideal exit: 18 Dec 2023 (T+270)
€564100 shares@ €5.640.0010% mcap0.5% of flow
ActionEuronext Growth Paris
2022DD868251·
Ideal exit: 10 Jul 2023 (T+270)
€600100 shares@ €6.000.0011% mcap0.5% of flow
ActionEuronext Growth Paris
2022DD866144·
Ideal exit: 8 Jul 2023 (T+270)
€1,105182 shares@ €6.070.0019% mcap0.9% of flow
ActionEuronext Growth Paris
2022DD865449·
Ideal exit: 30 Jun 2023 (T+270)
7 of 7 declarations
About jérémy pessiot
Jérémy Pessiot is one of the co-founders of AFYREN, a French greentech company focused on biomass valorization and renewable chemistry. He plays a key role in the group’s scientific and industrial development as Deputy CEO and R&D Director. His career is closely tied to the creation of AFYREN itself, which originated in Auvergne from research work conducted at the University of Clermont-Ferrand. That academic foundation shaped his professional path at the intersection of microbiology, bioprocess engineering, and industrial innovation. AFYREN states that he holds a PhD in microbiology and bioprocessing from Université Blaise Pascal in Clermont-Ferrand.
